O	0	8	Hedgehog	Hedgehog	NN	B-NP
O	9	18	signaling	signaling	NN	I-NP
O	18	19	:	:	:	O
O	20	30	networking	networking	NN	B-NP
O	31	33	to	to	TO	B-VP
O	34	41	nurture	nurture	VB	I-VP
O	42	43	a	a	DT	B-NP
B-Cancer	44	56	promalignant	promalignant	JJ	I-NP
I-Cancer	57	62	tumor	tumor	NN	I-NP
O	63	79	microenvironment	microenvironment	NN	I-NP
O	79	80	.	.	.	O

O	82	84	In	In	IN	B-PP
O	85	93	addition	addition	NN	B-NP
O	94	96	to	to	TO	B-PP
O	97	100	its	its	PRP$	B-NP
O	101	105	role	role	NN	I-NP
O	106	108	in	in	IN	B-PP
B-Developing_anatomical_structure	109	118	embryonic	embryonic	JJ	B-NP
O	119	130	development	development	NN	I-NP
O	130	131	,	,	,	O
O	132	135	the	the	DT	B-NP
O	136	144	Hedgehog	Hedgehog	NNP	I-NP
O	145	152	pathway	pathway	NN	I-NP
O	153	156	has	have	VBZ	B-VP
O	157	161	been	be	VBN	I-VP
O	162	167	shown	show	VBN	I-VP
O	168	170	to	to	TO	I-VP
O	171	173	be	be	VB	I-VP
O	174	176	an	an	DT	B-NP
O	177	183	active	active	JJ	I-NP
O	184	195	participant	participant	NN	I-NP
O	196	198	in	in	IN	B-PP
B-Cancer	199	205	cancer	cancer	NN	B-NP
O	206	217	development	development	NN	I-NP
O	217	218	,	,	,	O
O	219	230	progression	progression	NN	B-NP
O	230	231	,	,	,	O
O	232	235	and	and	CC	O
O	236	246	metastasis	metastasis	NN	B-NP
O	246	247	.	.	.	O

O	248	256	Although	Although	IN	B-SBAR
O	257	261	this	this	DT	B-NP
O	262	269	pathway	pathway	NN	I-NP
O	270	272	is	be	VBZ	B-VP
O	273	282	activated	activate	VBN	I-VP
O	283	285	by	by	IN	B-PP
O	286	295	autocrine	autocrine	JJ	B-NP
O	296	305	signaling	signaling	NN	I-NP
O	306	308	by	by	IN	B-PP
O	309	317	Hedgehog	Hedgehog	NN	B-NP
O	318	325	ligands	ligand	NNS	I-NP
O	325	326	,	,	,	O
O	327	329	it	it	PRP	B-NP
O	330	333	can	can	MD	B-VP
O	334	338	also	also	RB	I-VP
O	339	347	initiate	initiate	VB	I-VP
O	348	357	paracrine	paracrine	JJ	B-NP
O	358	367	signaling	signaling	NN	I-NP
O	368	372	with	with	IN	B-PP
B-Cell	373	378	cells	cell	NNS	B-NP
O	379	381	in	in	IN	B-PP
O	382	385	the	the	DT	B-NP
O	386	402	microenvironment	microenvironment	NN	I-NP
O	402	403	.	.	.	O

O	404	408	This	This	DT	B-NP
O	409	416	creates	create	VBZ	B-VP
O	417	418	a	a	DT	B-NP
O	419	426	network	network	NN	I-NP
O	427	429	of	of	IN	B-PP
O	430	438	Hedgehog	Hedgehog	NN	B-NP
O	439	448	signaling	signaling	NN	I-NP
O	449	453	that	that	WDT	B-NP
O	454	464	determines	determine	VBZ	B-VP
O	465	468	the	the	DT	B-NP
O	469	478	malignant	malignant	JJ	I-NP
O	479	487	behavior	behavior	NN	I-NP
O	488	490	of	of	IN	B-PP
O	491	494	the	the	DT	B-NP
B-Cell	495	500	tumor	tumor	NN	I-NP
I-Cell	501	506	cells	cell	NNS	I-NP
O	506	507	.	.	.	O

O	508	510	As	As	IN	B-PP
O	511	512	a	a	DT	B-NP
O	513	519	result	result	NN	I-NP
O	520	522	of	of	IN	B-PP
O	523	532	paracrine	paracrine	JJ	B-NP
O	533	539	signal	signal	NN	I-NP
O	540	552	transmission	transmission	NN	I-NP
O	552	553	,	,	,	O
O	554	557	the	the	DT	B-NP
O	558	565	effects	effect	NNS	I-NP
O	566	568	of	of	IN	B-PP
O	569	577	Hedgehog	Hedgehog	NNP	B-NP
O	578	587	signaling	signal	VBG	B-VP
O	588	592	most	most	RBS	B-VP
O	593	603	profoundly	profoundly	RB	I-VP
O	604	613	influence	influence	VB	I-VP
O	614	617	the	the	DT	B-NP
B-Cell	618	625	stromal	stromal	JJ	I-NP
I-Cell	626	631	cells	cell	NNS	I-NP
O	632	636	that	that	WDT	B-NP
O	637	647	constitute	constitute	VBP	B-VP
O	648	651	the	the	DT	B-NP
B-Cancer	652	657	tumor	tumor	NN	I-NP
O	658	674	microenvironment	microenvironment	NN	I-NP
O	674	675	.	.	.	O

O	676	679	The	The	DT	B-NP
B-Cell	680	687	stromal	stromal	JJ	I-NP
I-Cell	688	693	cells	cell	NNS	I-NP
O	694	696	in	in	IN	B-PP
O	697	701	turn	turn	NN	B-NP
O	702	709	produce	produce	VBP	B-VP
O	710	717	factors	factor	NNS	B-NP
O	718	722	that	that	WDT	B-NP
O	723	730	nurture	nurture	VBP	B-VP
O	731	734	the	the	DT	B-NP
B-Cancer	735	740	tumor	tumor	NN	I-NP
O	740	741	.	.	.	O

O	742	746	Thus	Thus	RB	B-ADVP
O	746	747	,	,	,	O
O	748	752	such	such	PDT	B-NP
O	753	754	a	a	DT	I-NP
O	755	765	resonating	resonate	VBG	I-NP
O	766	771	cross	cross	AFX	I-NP
O	771	772	-	-	HYPH	I-NP
O	772	776	talk	talk	NN	B-NP
O	777	780	can	can	MD	B-VP
O	781	788	amplify	amplify	VB	I-VP
O	789	797	Hedgehog	Hedgehog	NNP	B-NP
O	798	807	signaling	signaling	NN	I-NP
O	807	808	,	,	,	O
O	809	818	resulting	result	VBG	B-VP
O	819	821	in	in	IN	B-PP
O	822	831	molecular	molecular	JJ	B-NP
O	832	839	chatter	chatter	NN	I-NP
O	840	844	that	that	WDT	B-NP
O	845	852	overall	overall	RB	B-ADVP
O	853	861	promotes	promote	VBZ	B-VP
B-Cancer	862	867	tumor	tumor	NN	B-NP
O	868	879	progression	progression	NN	I-NP
O	879	880	.	.	.	O

O	881	891	Inhibitors	Inhibitor	NNS	B-NP
O	892	894	of	of	IN	B-PP
O	895	903	Hedgehog	Hedgehog	NN	B-NP
O	904	913	signaling	signaling	NN	I-NP
O	914	918	have	have	VBP	B-VP
O	919	923	been	be	VBN	I-VP
O	924	927	the	the	DT	B-NP
O	928	935	subject	subject	NN	I-NP
O	936	938	of	of	IN	B-PP
O	939	946	intense	intense	JJ	B-NP
O	947	955	research	research	NN	I-NP
O	955	956	.	.	.	O

O	957	964	Several	Several	JJ	B-ADJP
O	965	967	of	of	IN	B-PP
O	968	973	these	these	DT	B-NP
O	974	984	inhibitors	inhibitor	NNS	I-NP
O	985	988	are	be	VBP	B-VP
O	989	998	currently	currently	RB	I-VP
O	999	1004	being	be	VBG	I-VP
O	1005	1014	evaluated	evaluate	VBN	I-VP
O	1015	1017	in	in	IN	B-PP
O	1018	1026	clinical	clinical	JJ	B-NP
O	1027	1033	trials	trial	NNS	I-NP
O	1033	1034	.	.	.	O

O	1035	1039	Here	Here	RB	B-ADVP
O	1039	1040	,	,	,	O
O	1041	1043	we	we	PRP	B-NP
O	1044	1050	review	review	VBP	B-VP
O	1051	1054	the	the	DT	B-NP
O	1055	1059	role	role	NN	I-NP
O	1060	1062	of	of	IN	B-PP
O	1063	1066	the	the	DT	B-NP
O	1067	1075	Hedgehog	Hedgehog	NNP	I-NP
O	1076	1083	pathway	pathway	NN	I-NP
O	1084	1086	in	in	IN	B-PP
O	1087	1090	the	the	DT	B-NP
O	1091	1100	signature	signature	NN	I-NP
O	1101	1116	characteristics	characteristic	NNS	I-NP
O	1117	1119	of	of	IN	B-PP
B-Cell	1120	1126	cancer	cancer	NN	B-NP
I-Cell	1127	1132	cells	cell	NNS	I-NP
O	1133	1137	that	that	WDT	B-NP
O	1138	1147	determine	determine	VBP	B-VP
B-Cancer	1148	1153	tumor	tumor	NN	B-NP
O	1154	1165	development	development	NN	I-NP
O	1165	1166	,	,	,	O
O	1167	1178	progression	progression	NN	B-NP
O	1178	1179	,	,	,	O
O	1180	1183	and	and	CC	O
O	1184	1194	metastasis	metastasis	NN	B-NP
O	1194	1195	.	.	.	O

O	1196	1200	This	This	DT	B-NP
O	1201	1207	review	review	NN	I-NP
O	1208	1217	condenses	condense	VBZ	B-VP
O	1218	1221	the	the	DT	B-NP
O	1222	1228	latest	late	JJS	I-NP
O	1229	1237	findings	finding	NNS	I-NP
O	1238	1240	on	on	IN	B-PP
O	1241	1244	the	the	DT	B-NP
O	1245	1254	signaling	signaling	NN	I-NP
O	1255	1263	pathways	pathway	NNS	I-NP
O	1264	1268	that	that	WDT	B-NP
O	1269	1272	are	be	VBP	B-VP
O	1273	1282	activated	activate	VBN	I-VP
O	1283	1286	and	and	CC	O
O	1286	1287	/	/	SYM	B-NP
O	1287	1289	or	or	CC	O
O	1290	1299	regulated	regulate	VBN	B-VP
O	1300	1302	by	by	IN	B-PP
O	1303	1312	molecules	molecule	NNS	B-NP
O	1313	1322	generated	generate	VBN	B-VP
O	1323	1327	from	from	IN	B-PP
O	1328	1336	Hedgehog	Hedgehog	NN	B-NP
O	1337	1346	signaling	signaling	NN	I-NP
O	1347	1349	in	in	IN	B-PP
B-Cancer	1350	1356	cancer	cancer	NN	B-NP
O	1357	1360	and	and	CC	O
O	1361	1366	cites	cite	VBZ	B-VP
O	1367	1376	promising	promising	JJ	B-NP
O	1377	1385	clinical	clinical	JJ	I-NP
O	1386	1399	interventions	intervention	NNS	I-NP
O	1399	1400	.	.	.	O

O	1401	1408	Finally	Finally	RB	B-ADVP
O	1408	1409	,	,	,	O
O	1410	1412	we	we	PRP	B-NP
O	1413	1420	discuss	discuss	VBP	B-VP
O	1421	1427	future	future	JJ	B-NP
O	1428	1438	directions	direction	NNS	I-NP
O	1439	1442	for	for	IN	B-PP
O	1443	1454	identifying	identify	VBG	B-VP
O	1455	1458	the	the	DT	B-NP
O	1459	1470	appropriate	appropriate	JJ	I-NP
O	1471	1479	patients	patient	NNS	I-NP
O	1480	1483	for	for	IN	B-PP
O	1484	1491	therapy	therapy	NN	B-NP
O	1491	1492	,	,	,	O
O	1493	1503	developing	develop	VBG	B-VP
O	1504	1512	reliable	reliable	JJ	B-NP
O	1513	1520	markers	marker	NNS	I-NP
O	1521	1523	of	of	IN	B-PP
O	1524	1532	efficacy	efficacy	NN	B-NP
O	1533	1535	of	of	IN	B-PP
O	1536	1545	treatment	treatment	NN	B-NP
O	1545	1546	,	,	,	O
O	1547	1550	and	and	CC	O
O	1551	1560	combating	combat	VBG	B-VP
O	1561	1571	resistance	resistance	NN	B-NP
O	1572	1574	to	to	TO	B-PP
O	1575	1583	Hedgehog	Hedgehog	NNP	B-NP
O	1584	1591	pathway	pathway	NN	I-NP
O	1592	1602	inhibitors	inhibitor	NNS	I-NP
O	1602	1603	.	.	.	O

